CIMS India vs Nirog1
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CIMS India
This medical reference app provides healthcare professionals with a comprehensive drug database, disease management guidelines, and the latest medical news. It offers quick access to clinical information and expert insights to support informed decision-making at the point of care.
- Drug dosing and interaction information
- Disease management guidelines
- Latest medical news and updates
- Expert video interviews
- Concise and comprehensive drug database
Read full descriptionHide full description
For over 50 years, MIMS has provided trusted clinical information for over 2 million healthcare professionals in Asia. Designed for busy individuals on the go, the MIMS app is a one-stop medical resource to support clinical decisions at the point of care. The most trusted drug and medical reference tool for doctors in Asia. The MIMS Mobile app for IOS™ is available for free. For more information, visit www.mims.com/mobile-app __________________________________________________________________ Key features available in our app: • Drug Information Search for drug dosing information or specific drug interactions, and find the answers you need in seconds with our concise and comprehensive drug database. • Disease & Condition Management Guidelines Review a complete disease management guide and be assured of reliable content fully substantiated by validated references and internationally recognised research, to enable you to make better-informed prescribing decisions. • Medical News & CME Updates Read the latest news available across various specialties in Asia through our renowned publications (Medical Tribune, JPOG, Oncology Tribune, etc), and keep your knowledge and skills current with changes in medicine. • Multimedia Watch insightful video interviews focusing on treatment options, disease management and latest updates by experts from various specialties, and upgrade your medical knowledge.
Nirog1
This platform connects Ayurvedic doctors and students to discuss patient cases, learn about new developments, and register for educational events. It fosters a community for sharing experiences and insights within the world of Ayurveda.
- Discuss patient cases
- Learn about updates
- Register for workshops
- Enroll in courses
- Share experiences and insights
Read full descriptionHide full description
The World of Ayurveda Doctors and Students Nirog1 is an Ayurveda community exclusively meant for the Ayurvedic doctors and students, it is a smartphone based platform that enables both the practitioners and the students to discuss patient cases, learn about updates, register for workshops and CMEs, enroll in courses, etc. Learn, interact, contribute to the world of Ayurveda with your experiences, insights, and queries. प्रयोजनं चास्य स्वस्थस्य स्वास्थ्यरक्षणं आतुरस्यविकारप्रशमनं च|| (Charaka Sutra, Chapter 30, verse 26) [The utility of Ayurveda is to maintain the health of a healthy person and to cure the disease of the sick.]
Screenshots
Verdict
The clearest difference is review sentiment: Nirog1 at 78% against CIMS India's 25%. Nirog1 also leads on rating (5.0 vs 2.0) and ads (none vs shown). CIMS India's advantage is iOS requirement (12.4 vs 15.0). On price, ratings volume, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Nirog1 holds the better App Store score, 5.0 against 2.0. Both are backed by a comparable volume of ratings — 2 and 1 respectively. Written reviews point the same way: 25% of CIMS India's written reviews are positive against 78% of Nirog1's.
CIMS India ships an update every 2 months, Nirog1 every 3 weeks. The most recent releases landed on September 23, 2026 and October 8, 2026 respectively.
| Parameter | CIMS India | Nirog1 |
|---|---|---|
| Price | Free | Free |
| Rating | 2.0 (2 ratings) | 5.0 (1 ratings) — better |
| Positive reviews | 25.0% of reviews | 77.8% of reviews — better |
| Number of ratings | 2 — better | 1 |
| Update frequency | Every 2 months | Every 3 weeks — better |
| Ads | Yes | No — better |
| In-app purchases | No | No |
| Monetization | Ad-supported | Free — better |
| Devices | iPhone, iPad, iPod — better | iPhone, iPod |
| Requires iOS | 12.4 — better | 15.0 |
| Further details — not scored | ||
| Size | 44 MB | 178 MB |
| Age rating | 17+ | 12+ |
| Developer | MIMS PTE. LTD. | Hinirog Healthtech Private Limited |
Customer experience
CIMS India
Nirog1
In-app purchases
CIMS India
No in-app purchases
Nirog1
No in-app purchases
Questions
Is CIMS India free?
Is Nirog1 free?
Which has better reviews, CIMS India or Nirog1?
Do CIMS India or Nirog1 have ads?
Which is updated more often, CIMS India or Nirog1?
Other comparisons
